Tianjin Lisheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 17.5% in First Half of 2022

Tianjin Lisheng Pharmaceutical Co.,Ltd. (天津力生制药股份有限公司) (002393.SZ) reported a net profit of 72 million yuan in the first half of 2022, up 17.5% year-on-year.

Meanwhile, the company posted 614.7 million yuan in revenue, up 4.7% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 923.6 million yuan in total liabilities, with a liability-to-asset ratio of 17.3%.